PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-03

Date Title Company
03-Nov-2022 Orthobiologics Market Demand To Reach USD 6.5 billion By 2027 | Future Market Insights MARKITWIRED
03-Nov-2022 Bioabsorbable Stents Market to receive overwhelming hike USD 248.5 million in Revenues by 2032: Exclusive Report by FMI MARKITWIRED
03-Nov-2022 U.S. Digital Ovulation Test is likely to exceed a valuation of US$ 162.7 Million by 2032 | FMI MARKITWIRED
03-Nov-2022 Varicose Vein Treatment Market worth US$ 1.4 billion by 2032 – Exclusive Report by Future Market Insights, Inc. MARKITWIRED
03-Nov-2022 Infusion Pumps Market size was valued at US$ 4.4 Bn in 2022 and is expected to reach US$ 6.6 Bn by 2030 | FMI MARKITWIRED
03-Nov-2022 Portable Oxygen Concentrators Market Size Set to Witness an Uptick Size USD 5.0 billion to 2032: Future Market Insights, Inc. MARKITWIRED
03-Nov-2022 Central Venous Catheter Market share is reaching US$ 5.1 Bn at a gracious rate of 5.1% by the year 2032 MARKITWIRED
03-Nov-2022 Mesenchymal Stem Cells Market is estimated to be US$ 9.17 billion by 2032 with a CAGR of 12.8% during the forecast period Prophecy Market Insights
03-Nov-2022 Creative Enzymes Expands Its Probiotic Portfolio Creative Enzymes
03-Nov-2022 Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits Creative Enzymes
03-Nov-2022 Biophytis reports positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in COVID-19 Biophytis
03-Nov-2022 Pharmacovigilance World 2022 Virtual Conference Corvus Global Events
03-Nov-2022 Evotec completes acquisition of Central Glass Germany Evotec SE
03-Nov-2022 Broad-acting antiviral SARS-CoV-2 drug FYB207 shows longer half-life and improved efficacy through optimized molecular design in preclinical studies Formycon AG
03-Nov-2022 AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million AEVIS VICTORIA SA
03-Nov-2022 STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 STRATEC SE